Home| Journals | About Us|Contact Us|www.statperson.com
 
Untitled Document

[Abstract] [PDF] [HTML] [Linked References]

MedPulse - International Medical Journal, ISSN 2348-2516 E-ISSN: 2348-1897

Volume 1, Issue 2, April 2014 pp 186-188

Research Article

The comparative study between the efficacy of high dose of acyclovir and erythromycin on pityriasis rosea

Kakali Mridha1, Dayamay Pal2, Sukumar Jana3

1,2Assistant Professor, 3Associate Professor, Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, INDIA.


Academic Editor : Dr. Bhanap P. L.

Linked References

 

    1. Chuh AA, Molinari N, Sciallis G et al. Temporal case clustering in pityriasis rosea: a regression analysis on 1379 patient in Minesota, Kuwait and Diyarbakir, Turkey. Arch Dermatol 2005; 141: 767
    2. DeSouza Sittarf JA, Tayah M, Soares Z. Incidence of pityriasis rosea of Gibert in the Dermatology service of the Hospital do servidor public in the state of sao Paulo. Med Cutan Ibero Lat Am 1984; 12: 336-8
    3. Olumide Y. Pityriasis rosea in Lagos. Int J Dermatol 1987; 26: 234-6
    4. Case clustering in pityriasis rosea: support for the role of an infective agent. Br Med J (Clin Res Ed) 1982; 284; 977
    5. Chuch AA, Lee A, Molinari N. Case clustering in pityriasis rosea: a multicentre epidemiologic study in primary care settings in Hong Kong Arch Dermatol 2003; 139: 489-93
    6. Drago F Raneiri E, Malaguti F et el. Human herpesvirus 7 in pityriasis rosea Lancet 1997; 349: 1367-8
    7. Broccolo F, Drago F, Careddu AM, Foglieni C, Turbino L, Cocuzza CE et al/ Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and 7. J Invest Dermatol 2005; 124: 1234-40
    8. Watanabe T, Kawamura T, Jacob SE, Aquilino EA, Ornstein JM, Black JB et al. Pityriasis rosea is associated with systemic active infection with human herpesvirus -7 and human herpesvirus-6. J Invest Dermatol 2002; 119: 793-7
    9. Ardnt KA, Paul BS, Sterns RS et al. Treatment of pityriasis with UV radiation. Arch Dermatol 1983; 119: 381-382
    10. Sharma PK, Yadav TP, Goutam RK et al. Erythromycin in pityriasis rosea, a double blind placebo controlled clinical trial. J Am Acad Dermatol 2000; 42: 241-244
    11. Drago F, Vecchio F, Rebora A. Use of high dose of Acyclovir in Pityriasis rosea. J Am Acad Dermatol 2006; 54: 82-5
    12. Amirhooshang Ehsani, Nafiseh Esmaily, Pedram Noormohammadpour et al. The comparison between the efficacy of high dose of Acyclovir and Erythromycin on the period and signs of pityriasis rosea. Indian Journal of Dermatology, 2010; 55: 246-48
    13. Bukhari IA. Oral erythromycin is ineffective in the treatment of pityriasis rosea. J Drugs Dermatol 2008; 7: 625
    14. Rasi A, Tajziehchi L, Savabi NaSab S. Oral erythromycin is ineffective in the treatment of pityriasis rosea. J Drugs Dermatol 2008; 7: 35-8
    15. Bigby M. A remarkable result of double masked placebo controlled trial of erythromycin in the treatment of pityriasis. Arch dermatol 2000; 136; 775-76
 
 
 
 
 
 
     
  Copyrights statperson consultancy www

Copyrights © MedPulse Publishing Corporation www.medpulse.in  2017. All Rights Reserved.